|
4 Companies |
|
6 Products |
|
6 Products |
|
5 Mechanisms of Action |
|
0 Trials |
|
20 News |
|
- | Subgam (human normal immunoglobulin) / Bio Products Lab
Trial completion: Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases (clinicaltrials.gov) - Aug 7, 2017
P3, N=38, Completed, Sponsor: Bio Products Laboratory
Active, not recruiting --> Completed
- Subgam (human normal immunoglobulin) / Bio Products Lab
Enrollment closed, Enrollment change: Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases (clinicaltrials.gov) - Jan 4, 2017
P3, N=38, Active, not recruiting, Sponsor: Bio Products Laboratory
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=50 --> 38
- Subgam (human normal immunoglobulin) / Bio Products Lab
Trial primary completion date: Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases (clinicaltrials.gov) - Nov 29, 2016
P3, N=50, Recruiting, Sponsor: Bio Products Laboratory
Recruiting --> Active, not recruiting | N=50 --> 38 Trial primary completion date: Nov 2016 --> Jul 2017
- Subgam (human normal immunoglobulin) / Bio Products Lab
Enrollment change: Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases (clinicaltrials.gov) - Nov 15, 2016
P3, N=50, Recruiting, Sponsor: Bio Products Laboratory
Trial primary completion date: Nov 2016 --> Jul 2017 N=35 --> 50
- Trial completion, Trial primary completion date: Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells (clinicaltrials.gov) - Jun 23, 2016
P1/2, N=25, Completed, Sponsor: Children's Hospital Los Angeles
N=35 --> 50 Recruiting --> Completed | Trial primary completion date: Aug 2012 --> Aug 2015
- Gammaplex (intravenous normal human immunoglobulin) / Bio Products Lab
Trial completion, Trial primary completion date: GMX07: Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex (clinicaltrials.gov) - May 11, 2016
P3, N=48, Completed, Sponsor: Bio Products Laboratory
Recruiting --> Completed | Trial primary completion date: Aug 2012 --> Aug 2015 Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Jan 2016
- Gammaplex (intravenous normal human immunoglobulin) / Bio Products Lab
Trial primary completion date: GMX07: Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex (clinicaltrials.gov) - Jan 17, 2016
P3, N=48, Recruiting, Sponsor: Bio Products Laboratory
Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Jan 2016 Trial primary completion date: Sep 2015 --> Jun 2016
- Subgam (human normal immunoglobulin) / Bio Products Lab
Enrollment open: Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases (clinicaltrials.gov) - Aug 19, 2015
P3, N=35, Recruiting, Sponsor: Bio Products Laboratory
Trial primary completion date: Sep 2015 --> Jun 2016 Not yet recruiting --> Recruiting
- Subgam (human normal immunoglobulin) / Bio Products Lab
Trial initiation date, Trial primary completion date: Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases (clinicaltrials.gov) - Jun 11, 2015
P3, N=35, Not yet recruiting, Sponsor: Bio Products Laboratory
Not yet recruiting --> Recruiting Initiation date: Jan 2015 --> Aug 2015 | Trial primary completion date: Jan 2016 --> Nov 2016
- Gammaplex (intravenous normal human immunoglobulin) / Bio Products Lab
Trial completion: A Study to Find Out How Safe and Effective Gammaplex (clinicaltrials.gov) - May 26, 2014
P4, N=25, Completed, Sponsor: Bio Products Laboratory
Initiation date: Jan 2015 --> Aug 2015 | Trial primary completion date: Jan 2016 --> Nov 2016 Active, not recruiting --> Completed
- Gammaplex (intravenous normal human immunoglobulin) / Bio Products Lab
Enrollment open: GMX07: Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex (clinicaltrials.gov) - Feb 20, 2014
P3, N=48, Recruiting, Sponsor: Bio Products Laboratory
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Subgam (human normal immunoglobulin) / Bio Products Lab
Trial suspension: Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases (clinicaltrials.gov) - Jan 28, 2014
P3, N=35, Suspended, Sponsor: Bio Products Laboratory
Not yet recruiting --> Recruiting Not yet recruiting --> Suspended
- Subgam (human normal immunoglobulin) / Bio Products Lab
Trial initiation date: Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases (clinicaltrials.gov) - Jan 28, 2014
P3, N=35, Suspended, Sponsor: Bio Products Laboratory
Not yet recruiting --> Suspended Initiation date: Oct 2013 --> Jan 2015
- Subgam (human normal immunoglobulin) / Bio Products Lab
Enrollment change: Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases (clinicaltrials.gov) - Jan 28, 2014
P3, N=35, Suspended, Sponsor: Bio Products Laboratory
Initiation date: Oct 2013 --> Jan 2015 N=45 --> 35
- Gammaplex (intravenous normal human immunoglobulin) / Bio Products Lab
New P3 trial: GMX07: Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex (clinicaltrials.gov) - Oct 14, 2013
P3, N=48, Recruiting, Sponsor: Bio Products Laboratory
- Trial termination: Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States (clinicaltrials.gov) - Jul 11, 2013
P=N/A, N=119, Terminated, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=45 --> 35 Recruiting --> Terminated
- Enrollment change: Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States (clinicaltrials.gov) - Jul 11, 2013
P=N/A, N=119, Terminated, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Terminated N=600 --> 119
- Subgam (human normal immunoglobulin) / Bio Products Lab
New P3 trial: Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases (clinicaltrials.gov) - Jun 20, 2013
P3, N=35, Suspended, Sponsor: Bio Products Laboratory
- Gammaplex (intravenous normal human immunoglobulin) / Bio Products Lab
Enrollment closed: A Study to Find Out How Safe and Effective Gammaplex (clinicaltrials.gov) - Mar 21, 2013
P4, N=25, Active, not recruiting, Sponsor: Bio Products Laboratory
N=600 --> 119 Recruiting --> Active, not recruiting
- | Flebogamma 5% DIF (human immune globulin intravenous 5%) / Grifols
Trial completion: Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects (clinicaltrials.gov) - Aug 6, 2012
P4, N=25, Completed, Sponsor: Instituto Grifols, S.A.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed